SCHEMBL7562474

SCHEMBL7562474

N#Cc1cccc(NN=C(Cl)CF)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.43
KMT2A Q03164 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 2/20 0.43
HSD17B10 Q99714 2/20 0.43
TSHR P16473 2/20 0.43
CYP3A4 P08684 1/20 0.43
ALOX15 P16050 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CISD1 Q9NZ45 1/20 0.43
IDO1 P14902 1/20 0.42
LMNA P02545 1/20 0.42
GRM4 Q14833 1/20 0.41
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40
PDK4 Q16654 1/20 0.40
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7564392 0.82 MAPT (0.43) MAPTKMT2ASMN1; SMN2ALDH1A1MEN1
SCHEMBL7568401 0.79 PDK1 (0.46) MAPTKMT2ASMN1; SMN2ALDH1A1MEN1
SCHEMBL7644896 0.79 PDK1 (0.46) MAPTKMT2ASMN1; SMN2ALDH1A1MEN1
SCHEMBL3833229 0.73 PDK1 (0.46) MAPTKMT2ASMN1; SMN2ALDH1A1MEN1
SCHEMBL7567499 0.73 PDK1 (0.46) MAPTKMT2ASMN1; SMN2ALDH1A1MEN1
SCHEMBL25888267 0.73 PDK1 (0.49) MAPTKMT2ASMN1; SMN2ALDH1A1MEN1
SCHEMBL16361796 0.73 PDCD1 (0.50) MAPTKMT2ASMN1; SMN2ALDH1A1MEN1
SCHEMBL16324249 0.73 PDCD1 (0.50) MAPTKMT2ASMN1; SMN2ALDH1A1MEN1
SCHEMBL16324250 0.73 PDCD1 (0.50) MAPTKMT2ASMN1; SMN2ALDH1A1MEN1
SCHEMBL2905312 0.73 MAPT (0.53) MAPTKMT2ASMN1; SMN2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222172-A1 SYNTHESIS OF 1,3,5-TRISUBSTITUTED PYRAZOLES AND INTERMEDIATES THEREFORE Bristol-Myers Squibb Pharma Company (US) 2002-07-17 EP disclosed
WO-2001029006-A1 SYNTHESIS OF 1,3,5-TRISUBSTITUTED PYRAZOLES AND INTERMEDIATES THEREFORE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-04-26 WO disclosed